Why Would Mounjaro Not Work for You?

Is the dose actually high enough to do its job?

A question our prescribers hear most weeks is some version of: "I've been on Mounjaro for two months and nothing's happened." The first thing they ask back is which dose. The 2.5mg starting pen exists entirely for tolerability, its job is settling your system, not shifting weight. Most people need to move through the titration schedule, guided by their prescriber, before the medicine reaches a therapeutically meaningful level. Stalling at a lower dose because side effects felt manageable, or because no one prompted a review, is one of the most common reasons progress underwhelms.

NICE's appraisal of tirzepatide (TA1026) notes that if a patient hasn't lost at least 5% of their body weight after six months at the highest tolerated dose, continuing should be reviewed. That six-month clock starts once you've reached the highest dose you can manage, not from day one on 2.5mg. If you haven't had a structured review conversation, that's the place to start. Read more about what makes the medicine effective on our page on why Mounjaro works so well.

Transfer patients, or those who have been on the same dose for longer than expected, should ask their prescriber directly whether they are on the right step of the schedule. Dose management is clinical; it cannot be self-directed.

Could your diet, activity or alcohol be undoing the effect?

Tirzepatide reduces appetite through its dual action on GIP and GLP-1 receptors. What it does not do is override a significant calorie surplus. When hunger falls, some people unconsciously compensate by choosing calorie-dense foods, not because they are hungrier, but because hunger is less of a brake on habitual eating. Others find their activity levels drop because they feel more fatigued in the early weeks, which can cancel out some of the calorie reduction from eating less.

Alcohol is worth flagging specifically. It carries calories that GLP-1 medicines do not suppress appetite for, and some people find tolerance changes on treatment. A glass of wine that used to feel like nothing can hit harder, and the calories still count.

The guide to maximising results on Mounjaro covers practical steps around food quality, protein intake and keeping activity up without overdoing it early in treatment. There's no need for extreme restriction, but a reduced appetite is only useful if the food choices made in that window are reasonably balanced.

Are there underlying health conditions or medicines getting in the way?

This is where a thorough clinical review earns its keep. Several conditions are known to slow the body's response to weight-loss treatment: hypothyroidism (especially undertreated), polycystic ovary syndrome, high cortisol, significant insulin resistance and certain antidepressants or antipsychotics that independently promote weight gain. None of these make Mounjaro useless, but they can mean a slower or smaller response than clinical trial averages suggest.

If you have type 2 diabetes and are using Mounjaro for blood sugar as well as weight management, the interaction with your existing medication matters. Some combinations require careful adjustment, something a prescriber needs to oversee. Our page on who should not take Mounjaro covers contraindications and conditions that warrant close monitoring.

It is also worth raising any new medicines you have started since beginning treatment. Corticosteroids, some blood pressure medicines and various other drugs can counteract weight loss even on an otherwise effective regimen. Be specific with your prescriber about everything you take, including supplements.

Could a practical issue (the pen, the injection, the storage) be reducing your dose?

This one gets overlooked because it feels too simple, but it genuinely happens. Mounjaro pens must be refrigerated at 2–8°C. If a pen has spent time at room temperature beyond the window stated in the patient information leaflet, the medicine degrades and the dose you inject may be significantly less than the label says. Similarly, if the injection is not administered correctly (too shallow, too fast, or into an area with scar tissue from repeated use) absorption is inconsistent.

Rotating injection sites (abdomen, thigh, upper arm) matters more than most people realise. Injecting repeatedly into the same small area builds up local tissue changes that reduce absorption over time. The NHS tirzepatide medicines page sets out injection and storage guidance clearly; the patient information leaflet in your pen box is the definitive reference.

If you suspect a pen may have been affected by temperature exposure or you're not confident in your technique, speak to a prescriber rather than simply repeating the dose. Our team at the Mounjaro treatment page can help you raise a clinical query, and you can find general support through our contact page.

If you have been on treatment for a while and are finding results have plateaued or never materialised, it may also be worth exploring the personal factors that vary from one patient to another. There is also a broader look at circumstances where the medicine is less likely to suit someone on our page for that specific question. And if you want to understand the cost picture alongside the clinical one, our Mounjaro price comparison covers what private treatment typically involves in the UK.

If you'd like a prescriber to look at your situation specifically, speak to our prescribers through a free consultation, they review every case the same day.